Vaccine approval before phase 3 trial results: a consequence of vaccine access inequity. Nunez I. Lancet 2022 Mar 2. pii: S0140-6736(22)00164.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nunez I. Vaccine approval before phase 3 trial results: a consequence of vaccine access inequity. Lancet 2022 Mar 2. pii: S0140-6736(22)00164.
PMID: 35247309